BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38560081)

  • 21. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
    Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
    BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of adherence to current guidelines for treatment of hyperlipidemia in adults in an outpatient setting.
    Ng C; Chung P; Toderika Y; Cheng-Lai A
    Am J Health Syst Pharm; 2016 Dec; 73(23 Supplement 6):S133-S140. PubMed ID: 27864236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of post-myocardial infarction lipid levels and management: Results from a tertiary care hospital of Pakistan.
    Rauf R; Soomro MI; Khan MN; Kumar M; Soomro NA; Kazmi KA
    World J Cardiol; 2024 May; 16(5):282-292. PubMed ID: 38817645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction.
    Solomon MD; Leong TK; Levin E; Rana JS; Jaffe MG; Sidney S; Sung SH; Lee C; DeMaria A; Go AS
    J Am Heart Assoc; 2020 Mar; 9(6):e014415. PubMed ID: 32131689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detailed Lipid Profiles and Lipid-related Residual Risk after 12-week 10 mg Rosuvastatin Treatment for Acute Myocardial Infarction.
    Kondo Y; Ishida M; Ishisone T; Niiyama M; Osaki T; Matsumoto Y; Maegawa Y; Sasaki K; Ninomiya R; Takahashi Y; Ishikawa Y; Kimura T; Shimoda Y; Morikawa M; Saito H; Itoh T; Morino Y
    Intern Med; 2024 Mar; ():. PubMed ID: 38494714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of the 2013 ACC/AHA cholesterol guidelines on contemporary clinical practice for patients with atherosclerotic coronary and peripheral arterial disease.
    Gunasekaran P; Jeevanantham V; Sharma S; Thapa R; Gupta K
    Indian Heart J; 2017; 69(4):464-468. PubMed ID: 28822512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperlipidemia medication management in patients admitted for a myocardial infarction.
    Shuster JE; Jeffres MN; Barclay SM; Bhakta R
    Pharm Pract (Granada); 2011 Jan; 9(1):31-6. PubMed ID: 25132887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular Risk and Statin Eligibility in Primary Prevention: A Comparison between the Brazilian and the AHA/ACC Guidelines.
    Cesena FHY; Valente VA; Santos RD; Bittencourt MS
    Arq Bras Cardiol; 2020 Sep; 115(3):440-449. PubMed ID: 33027365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry.
    De Luca L; Arca M; Temporelli PL; Meessen J; Riccio C; Bonomo P; Colavita AR; Gabrielli D; Gulizia MM; Colivicchi F;
    Int J Cardiol; 2020 Oct; 316():229-235. PubMed ID: 32470532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III.
    Kern DM; Balu S; Tunceli O; Anzalone D
    Curr Med Res Opin; 2014 Dec; 30(12):2443-51. PubMed ID: 25280070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i.
    Mackinnon ES; Har B; Champsi S; Wani RJ; Geyer L; Shaw E; Farris MS; Anderson TJ
    Cardiol Ther; 2023 Jun; 12(2):327-338. PubMed ID: 36656500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
    Bellows BK; Olsen CJ; Voelker J; Wander C
    J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal low-density lipoprotein cholesterol target level in Korean acute myocardial infarction patients (<70 mg/dL vs. <55 mg/dL): Based on Korea acute myocardial infarction registry-National Institute of Health.
    Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Cho KH; Hyun DY; Lee SH; Kim HS; Gwon HC; Seong IW; Hur SH; Oh SK
    Int J Cardiol; 2022 Mar; 351():15-22. PubMed ID: 34921900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
    Pagidipati NJ; Navar AM; Mulder H; Sniderman AD; Peterson ED; Pencina MJ
    JAMA; 2017 Apr; 317(15):1563-1567. PubMed ID: 28418481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease.
    Sajja A; Li HF; Spinelli KJ; Ali A; Virani SS; Martin SS; Gluckman TJ
    Am J Prev Cardiol; 2021 Sep; 7():100187. PubMed ID: 34611633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
    Pokharel Y; Tang F; Jones PG; Nambi V; Bittner VA; Hira RS; Nasir K; Chan PS; Maddox TM; Oetgen WJ; Heidenreich PA; Borden WB; Spertus JA; Petersen LA; Ballantyne CM; Virani SS
    JAMA Cardiol; 2017 Apr; 2(4):361-369. PubMed ID: 28249067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
    Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
    BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.